Drug Profile
Research programme: nitric oxide donors - Lacer
Alternative Names: LA-8045Latest Information Update: 29 Jul 2022
Price :
$50
*
At a glance
- Originator Lacer
- Class Nitroso compounds; S-nitrosothiols
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Acute coronary syndromes; Stroke
Most Recent Events
- 27 Jul 2022 Lacer has been acquired by Italfarmaco
- 04 Nov 2017 No recent reports of development identified for preclinical development in Acute coronary syndromes in Spain
- 04 Nov 2017 No recent reports of development identified for preclinical development in Stroke in Spain